Thanks @Sawvic, that is one very well put together analysis from a firm that has a proven track record of picking winners.
It presents a compelling case for this now highly de-risked, but still speculative investment. (Rose coloured glasses perhaps) but if I had just come across NEU and read this report I would be 'in like Flynn' at the current SP.
A De-risked bio-tech with 4X upside - Karst Peak Capital, page-3
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$15.31 |
Change
-0.440(2.79%) |
Mkt cap ! $1.931B | |||
| Open | High | Low | Value | Volume |
| $15.80 | $15.80 | $15.19 | $5.515M | 356.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 159 | $15.30 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.31 | 103 | 6 |
View Market Depth
| Last trade - 14.52pm 23/07/2025 (20 minute delay) ? |
| NEU (ASX) Chart |